Skip to main content

IDEA Forum (Professor Zun-You Wu)

Speaker: Professor Zun-You Wu, Chief Epidemiologist, Chinese Center for Disease Control and Prevention

Topic: COVID-19 relevant study design, research methodology and results interpretation 

Watch the recording!

Related articles

Wu, Z., McGoogan, J.M. Asymptomatic and Pre-Symptomatic COVID-19 in China. Infect Dis Poverty 9, 72 (2020).

Zhou, L., Liu, J., Dong, X. et al. COVID-19 seeding time and doubling time model: an early epidemic risk assessment tool. Infect Dis Poverty 9, 76 (2020).

Related article collections

Transmission patterns and control of COVID-19 epidemic

Containment and case management of COVID-19 pandemic

Community management and recovery from COVID-19 pandemic

About the speaker

Zun-You Wu © Zun-You WuZunyou Wu, MD, PhD, is the Chief Epidemiologist of Chinese Center for Disease Control and Prevention, and an Adjunct Professor of Epidemiology at University of California at Los Angeles. He is a member of UNAIDS Scientific Expert Panel. Dr. Wu has worked in HIV/AIDS for 30 years and is a leader in HIV prevention strategies and oversees overall prevention among key populations in China. He has also worked in responses to SARS in 2003 and to COVID-19 in 2020. He has published over 500 academic papers, 263 of which in international journals, including Science, Lancet, JAMA. He has two publications on COVID-19 in Infectious Diseases of Poverty in 2020. Dr. Wu has received many honors including the 2005 International Rolleston Award for implementing harm reduction in China,Hall of Fame” of 2006 UCLA School of Public Health's Alumni, UNAIDS Gold Medal in 2008, and many awards from Chinese government.

Annual Journal Metrics

  • 2022 Citation Impact
    8.1 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.984 - SNIP (Source Normalized Impact per Paper)
    1.692 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    118 days submission to accept (Median)

    2023 Usage
    1,127 Altmetric mentions